{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:34:28Z","timestamp":1783967668970,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","award":["2023BP0202"],"award-info":[{"award-number":["2023BP0202"]}],"id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","award":["2024BP0101"],"award-info":[{"award-number":["2024BP0101"]}],"id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cellsig.2026.112478","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:48:11Z","timestamp":1773161291000},"page":"112478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protein 4.1R regulates CCDC26 and impacts myeloid leukemia progression"],"prefix":"10.1016","volume":"143","author":[{"given":"Luyang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112478_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112478_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0955-0674(99)00080-0","article-title":"The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton","volume":"12","author":"Hoover","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112478_bb0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1172\/JCI3858","article-title":"Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities","volume":"103","author":"Shi","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112478_bb0020","article-title":"Precision medicine for acute lymphoblastic leukemia in children: a review","volume":"11","author":"Ray","year":"2024","journal-title":"Children (Basel)"},{"issue":"20","key":"10.1016\/j.cellsig.2026.112478_bb0025","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112478_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jss.400010308","article-title":"Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents","volume":"1","author":"Yu","year":"1973","journal-title":"J. Supramol. Struct."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112478_bb0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI110275","article-title":"Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability","volume":"68","author":"Tchernia","year":"1981","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112478_bb0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.13085","article-title":"Protein 4.1R negatively regulates CD8(+) T-cell activation by modulating phosphorylation of linker for activation of T cells","volume":"157","author":"Fan","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.cellsig.2026.112478_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111546","article-title":"Protein 4.1R regulates M1 macrophages polarization via glycolysis, alleviating sepsis-induced liver injury in mice","volume":"128","author":"Sang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.cellsig.2026.112478_bb0050","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2008-10-182329","article-title":"Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT","volume":"113","author":"Kang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2026.112478_bb0055","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.12659\/MSM.914085","article-title":"Expression of protein 4.1 family in breast cancer: database mining for 4.1 family members in malignancies","volume":"25","author":"Feng","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112478_bb0060","first-page":"679","article-title":"Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer","volume":"28","author":"Zheng","year":"2009","journal-title":"Ai Zheng"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112478_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41389-021-00353-8","article-title":"Suppression of 4.1R enhances the potency of NKG2D-CAR T cells against pancreatic carcinoma via activating ERK signaling pathway","volume":"10","author":"Gao","year":"2021","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112478_bb0070","first-page":"72","article-title":"K562--a human leukemia cell line with erythroid features","volume":"18","author":"Gahmberg","year":"1981","journal-title":"Semin. Hematol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112478_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0145-2126(90)90002-Q","article-title":"Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts","volume":"14","author":"Alitalo","year":"1990","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112478_bb0080","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s12013-025-01722-5","article-title":"MiR-218 exhibits anti-Leukemia effects by targeting CTNND2 in primary acute erythroid Leukemia HEL cells","volume":"83","author":"Chu","year":"2025","journal-title":"Cell Biochem. Biophys."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112478_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cells14211721","article-title":"Acute myeloid leukemia: a key role of DGKalpha and DGKzeta in cell viability","volume":"14","author":"Gorla","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112478_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02041244","article-title":"The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation","volume":"47","author":"Auwerx","year":"1991","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112478_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112478_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720986080","article-title":"LncRNA CCDC26 interacts with CELF2 protein to enhance myeloid Leukemia cell proliferation and invasion via the circRNA_ANKIB1\/miR-195-5p\/PRR11 axis","volume":"30","author":"Li","year":"2021","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112478_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/gtc.70034","article-title":"Long noncoding RNA CCDC26 interacts with vimentin, HNRNPC, CBX1, and CBX5 proteins in multiple intracellular compartments of myeloid Leukemia cells","volume":"30","author":"Tanaka","year":"2025","journal-title":"Genes Cells"},{"key":"10.1016\/j.cellsig.2026.112478_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0364-7","article-title":"Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression","volume":"14","author":"Hirano","year":"2015","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112478_bb0115","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.27271","article-title":"Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management","volume":"99","author":"Patnaik","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112478_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112478_bb0125","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/MCB.02021-07","article-title":"Downregulation of protein 4.1R, a mature centriole protein, disrupts centrosomes, alters cell cycle progression, and perturbs mitotic spindles and anaphase","volume":"28","author":"Krauss","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112478_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2016.05.029","article-title":"Integrative functional genomics implicates EPB41 dysregulation in hepatocellular carcinoma risk","volume":"99","author":"Yang","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112478_bb0135","first-page":"2203","article-title":"lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia","volume":"18","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cellsig.2026.112478_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112897","article-title":"ROCK2 increases drug resistance in acute myeloid leukemia via metabolic reprogramming and MAPK\/PI3K\/AKT signaling","volume":"140","author":"Yan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112478_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1390456","article-title":"SPAG6 overexpression decreases the pro-apoptotic effect of daunorubicin in acute myeloid leukemia cells through the ROS\/JNK MAPK axis in a GSTP1-dependent manner","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112478_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0312406","article-title":"Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells","volume":"19","author":"Sato-Nagaoka","year":"2024","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112478_bb0155","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17474086.2022.2108015","article-title":"Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations","volume":"15","author":"He","year":"2022","journal-title":"Expert Rev. Hematol."},{"issue":"27","key":"10.1016\/j.cellsig.2026.112478_bb0160","doi-asserted-by":"crossref","first-page":"42683","DOI":"10.18632\/oncotarget.7977","article-title":"MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia","volume":"7","author":"Chakraborty","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112478_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115442","article-title":"AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK\/miR-22\/HuR axis in chronic myeloid leukemia cells","volume":"209","author":"Lee","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112478_bb0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12032-024-02398-2","article-title":"p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway","volume":"41","author":"Wang","year":"2024","journal-title":"Med. Oncol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112478_bb0175","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1080\/15384101.2022.2074624","article-title":"lncRNA TUG1 promotes the development of oral squamous cell carcinoma by regulating the MAPK signaling pathway by sponging miR-593-3p","volume":"21","author":"Jiang","year":"2022","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112478_bb0180","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s11596-024-2949-0","article-title":"LncRNA H19 activates the RAS-MAPK Signaling pathway via miR-140-5p\/SOS1 Axis in malignant liver Tumors","volume":"44","author":"Yu","year":"2024","journal-title":"Curr. Med. Sci."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112478_bb0185","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1007\/s12035-022-03015-x","article-title":"LncRNA SNHG25 promotes glioma progression through activating MAPK Signaling","volume":"59","author":"Wu","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112478_bb0190","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.7150\/thno.74753","article-title":"Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112478_bb0195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jhep.2020.05.028","article-title":"Peptide SMIM30 promotes HCC development by inducing SRC\/YES1 membrane anchoring and MAPK pathway activation","volume":"73","author":"Pang","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112478_bb0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13046-025-03465-w","article-title":"Non-canonical activation of MAPK signaling by the lncRNA ASH1L-AS1-encoded microprotein APPLE through inhibition of PP1\/PP2A-mediated ERK1\/2 dephosphorylation in hepatocellular carcinoma","volume":"44","author":"Zhao","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112478_bb0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15384101.2021.1979773","article-title":"NPSR1-AS1 activates the MAPK pathway to facilitate thyroid cancer cell malignant behaviors via recruiting ELAVL1 to stabilize NPSR1 mRNA","volume":"21","author":"Ni","year":"2022","journal-title":"Cell Cycle"},{"issue":"23","key":"10.1016\/j.cellsig.2026.112478_bb0210","doi-asserted-by":"crossref","first-page":"784","DOI":"10.21037\/atm.2019.11.36","article-title":"LncRNA MATN1-AS1 prevents glioblastoma cell from proliferation and invasion via RELA regulation and MAPK signaling pathway","volume":"7","author":"Han","year":"2019","journal-title":"Ann. Transl. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:32:06Z","timestamp":1776101526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826001294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S0898656826001294"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112478","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein 4.1R regulates CCDC26 and impacts myeloid leukemia progression","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112478"}}